GREENFIELD, Ind., Dec. 19,
2024 /PRNewswire/ -- Elanco Animal Health
Incorporated (NYSE: ELAN) will participate in the 43rd
Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Jeff Simmons, president and CEO, will represent
the company and respond to questions from analysts at 3:00 p.m. PST (6:00 PM
EST).
A live audio webcast will be available in the "Events and
Presentations" section of Elanco's investor website. A replay will
be available for approximately 30 days.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE:
ELAN) is a global leader in animal health dedicated to innovating
and delivering products and services to prevent and treat disease
in farm animals and pets, creating value for farmers, pet owners,
veterinarians, stakeholders and society as a whole. With nearly 70
years of animal health heritage, we are committed to helping our
customers improve the health of animals in their care, while also
making a meaningful impact on our local and global communities. At
Elanco, we are driven by our vision of Food and Companionship
Enriching Life and our Elanco Healthy Purpose– all to advance the
health of animals, people, the planet and our enterprise. Learn
more at www.elanco.com.
Investor Contact: Katy Grissom
(317) 273-9284 kathryn.grissom@elancoah.com
Media Contact: Colleen Parr Dekker
(317) 989-7011 colleen_parr_dekker@elancoah.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/elanco-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302336349.html
SOURCE Elanco Animal Health